Quantcast

Latest Cystic fibrosis Stories

2014-02-06 23:25:01

ResearchMoz.us include new market research report "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports. Full Report @ http://www.researchmoz.us/cystic-fibrosis-therapeutics-in-major-developed-markets-to-2019-cftr-modulators-initiate-drive-towards-personalized-treatment-and-market-growth-report.html Albany, NewYork (PRWEB) February 06, 2014 GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major...

2014-01-25 23:03:29

AIReS’ offices and team members found many ways to give back during the holiday season. Pittsburgh, PA (PRWEB) January 25, 2014 AIReS encourages our employees to give back to the community, through company-sponsored initiatives, office benefit drives, and individual volunteer opportunities. Each holiday season, our dedicated staff members continue to inspire us in the ways they give back. Here are some highlights: Each year our company supports several charities. This year, donations on...

2014-01-23 08:30:37

REHOVOT, Israel, January 23, 2014 /PRNewswire/ -- Advanced Inhalation Therapies (AIT), a leader in the development of nitric oxide (NO) therapeutics for the treatment of infectious respiratory diseases, announced today that its lead investigator will present clincial trial results at the upcoming 2014 American Thoracic Society (ATS) International Conference Committee in San Diego, California, May16 to 21, 2014. The presentation entitled "Prospective, double-blind,...

2014-01-14 23:21:24

Grant to Fulfill Wishes for Children Living with Cystic Fibrosis Narberth, PA (PRWEB) January 14, 2014 The Take a Breather Foundation is proud to announce that they have been awarded a $25,000 grant from the Julianna Hike Fund-Endowed of The Philadelphia Foundation. This grant will help the Take A Breather Foundation further it's mission of fulfilling wishes for children living with cystic fibrosis (CF). The Julianna Hike Fund focuses its support on organizations assisting children or...

2014-01-08 12:30:46

ATLANTA, Jan. 8, 2014 /PRNewswire/ -- The Celtaxsys Board of Directors today announced that Greg Duncan has been appointed as President and Chief Executive Officer (CEO) and will join the board of directors effective immediately. Mr. Duncan joins Celtaxsys following his most recent role as an Executive Committee member and President of North America for Brussels based UCB, prior to which he served as a Senior Vice-President at Pfizer where his duties included leading US marketing, as...

2014-01-07 12:27:31

Enrollment in the Multicenter Trial Begins in Soroka Medical Center in Israel REHOVOT, Israel, January 7, 2014 /PRNewswire/ -- Advanced Inhalation Therapies (AIT Ltd.), an Israeli drug development company, announced today that it has begun enrollment in Israel for a multicenter, open label, Phase II clinical trial of NOxCureCF, a respiratory treatment for patients with cystic fibrosis (CF). NOxCureCF is a specialized formulation of inhaled Nitric Oxide (NO) delivered using...

2013-12-30 12:21:41

BETHESDA, Md., Dec. 30, 2013 /PRNewswire-USNewswire/ -- Since the National Human Genome Project first revealed the human genome sequence, work began in earnest on how to apply this remarkable new knowledge to patient care. In an important step in helping current physicians and other healthcare professionals who are not board-certified geneticists to understand genomics in the clinical setting, the American College of Medical Genetics and Genomics (ACMG) has just created a series of...

Scientists Use Drug To Repair Rare Birth Defect
2013-12-22 17:37:52

University of British Columbia Success in mouse model is first instance of drug reversing a congenital deformity University of British Columbia and Vancouver Coastal Health scientists have developed a potential cure for a rare eye disease, showing for the first time that a drug can repair a birth defect. They formulated the drug Ataluren into eye drops, and found that it consistently restored normal vision in mice who had aniridia (ANN-uh-ridee- uh), a condition that severely limits...

2013-12-20 13:27:32

Investigators Add Immune System Dimension to Discussion of Microbiota and Disease Scroll down to listen to an explanation of how scientists think the microbiome, disease, and the immune system are related. Saint Louis University researchers have analyzed the microbiomes of people with chronic rhinosinusitis and healthy volunteers and found evidence that some chronic sinus issues may be the result of inflammation triggered by an immune response to otherwise harmless microorganisms in...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'